• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
CommentaryHealth

How an ideological war over PrEP threatens preventive services from smoking cessation to contraception to vaccines for half the U.S. population

By
Ari Hoffman
Ari Hoffman
and
Lauryn Claassen
Lauryn Claassen
Down Arrow Button Icon
By
Ari Hoffman
Ari Hoffman
and
Lauryn Claassen
Lauryn Claassen
Down Arrow Button Icon
July 9, 2024, 6:33 AM ET
Dr. Ari Hoffman is the Chief Clinical Officer and SVP of product at Collective Health, where he aims to improve the value of healthcare for employees and their dependents. He is also a practicing Internal Medicine doctor at UCSF. Lauryn Claassen is a UX writer and educator who works at the intersection of technology, public health promotion, and human-centered design.
Pre-Exposure Prophylaxis (PrEP) is a highly effective HIV prevention medication and a key part of the national plan to fight HIV in the U.S.
Pre-Exposure Prophylaxis (PrEP) is a highly effective HIV prevention medication and a key part of the national plan to fight HIV in the U.S.Jahi Chikwendiu - The Washington Post - Getty Images

Healthcare in the United States is notoriously complicated. In the absence of comprehensive national coverage, most Americans have employer-sponsored insurance. It is by far the most common source of health benefits in the U.S., with nearly 75% of working adults (and half of our nation’s children, as dependents) receiving health coverage from their employers.

As a player in the employer-sponsored healthcare space, we see firsthand the care, energy, and dedication that human resource and benefits teams at leading companies across the country have for their employee’s well-being. We’ve seen benefit teams make mid-year plan changes to provide better support during the pandemic, aim to do better than the status quo, and center health benefits in their people strategies.

More than anything, we see companies trying to nudge their employees into the lowest-cost, highest-reward behavior: prevention. This is a great strategy. One of the best ways for employers to support their employees and their families—while keeping an eye on costs—is by prioritizing and promoting preventive care.

The return on investment might take longer, but preventive care is critical for population health. Preventive services can help identify illnesses or risks earlier, manage care more effectively, and treat issues before they develop into more complicated, debilitating, and expensive conditions. Even if you’re looking at your health benefits strategy from a purely dollars-and-cents perspective, prioritizing preventive coverage just makes sense.

And while it’s always been a cost-effective and compassionate decision for employers to invest in their workforce by offering preventive care and services, it wasn’t until the Affordable Care Act (ACA) was passed in 2010 that employers were actually compelled to provide these benefits.

Since its passage, the ACA has required employers to cover certain preventive services without any cost-sharing like copays, coinsurance, or deductibles. More than 150 million Americans now have access to preventive services—and these are popular across the political spectrum: Polling shows that 80% of Democrats and 50% of Republicans support this provision of the ACA.

However, Braidwood v. Becerra, a case recently decided by the Fifth Circuit Court of Appeals and likely headed to the Supreme Court, is trying to chip away at the most popular, affordable, and impactful parts of the ACA.

Last year, Texas-based federal Judge Reed O’Connor moved to block the requirement for employers to offer certain zero-cost preventive services, including programs to help people quit tobacco products, HIV prevention medication coverage, and preventive screenings for anxiety, hypertension, and hepatitis B and C. The decision was appealed by the federal government. 

The Fifth Circuit upheld the national requirements for now, saying the lower court went too far on that front. However, the court agreed with the plaintiffs that the members of the U.S. Preventive Services Task Force, an independent panel of experts staffed by the Department of Health, should instead be nominated by the president and confirmed by the Senate. The Fifth Circuit called on the lower court to challenge the constitutionality of the federal agencies that recommend preventive services like vaccines and care for women and children. The ruling narrows the scope of the case—but sets a dangerous precedent for others looking to strip coverage for preventive services, and leaves preventive service coverage at risk.

The real focal point of this ruling was Pre-Exposure Prophylaxis (PrEP), a highly effective HIV prevention medication and a key part of the national plan to fight HIV in the U.S. This appears to be a targeted attack on PrEP on ideological grounds, and the ruling not only ignores science but also erodes decades of public health gains. Numerous studies from around the world have shown that PrEP programs effectively prevent HIV—saving lives and preventing costly care.

This case goes even further by challenging the authority of the U.S. Preventive Services Task Force and could impact the cost-sharing of other important services like hepatitis screenings. By catching and treating this disease early, people (and their employers, who will shoulder the cost) can avoid devastating liver failure and its many complications like transplants, multiple medications, repeated hospitalizations, and follow-ups for the rest of their lives. 

So much pain, disruption, and costly care can be prevented by routine screenings and effective treatment. And yet sometimes the simplest and most valuable steps, like routine screenings, can be the hardest to take. Understanding, accessing, and actually using health insurance is incredibly confusing, and when there’s a cost barrier in the way, it can keep people from accessing the care they need. It’s just hard to be a savvy shopper in our current healthcare landscape. Which is why it’s even more important to ensure the right choice is the easiest one to make. The more we can remove barriers to preventive care, the better.

If you’re an employer looking for the secret to low-cost, high-impact ways to recruit and retain talent while fostering a healthy and productive workforce, prioritize preventive healthcare coverage and remove barriers like copays, coinsurance, and deductibles.

True wellness requires preventive care. We’re calling on employers, HR, and benefit administrators to look past the legal and political battles and to keep doing what you’ve been doing. Prioritize zero-cost preventive care for your employees and their families. You will be rewarded with a healthier team and a healthier bottom line, today, tomorrow, and for years to come.

More must-read commentary published by Fortune:

  • How U.S.-China competition is benefiting the world—and reshaping the global economy
  • ‘A head-in-the-sand approach’: The U.S. strategic drug stockpile is inadequate for a bird flu outbreak
  • The national debt is over $34 trillion. It’s time to tell the truth about the U.S. government’s finances
  • Fearless Fund counsel: The court ruling barring grants to Black women entrepreneurs should terrify CEOs

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune.

Join us at the Fortune Workplace Innovation Summit May 19–20, 2026, in Atlanta. The next era of workplace innovation is here—and the old playbook is being rewritten. At this exclusive, high-energy event, the world’s most innovative leaders will convene to explore how AI, humanity, and strategy converge to redefine, again, the future of work. Register now.
About the Authors
By Ari Hoffman
See full bioRight Arrow Button Icon
By Lauryn Claassen
See full bioRight Arrow Button Icon

Latest in Commentary

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Commentary

powell/trump
CommentaryFederal Reserve
Is Powell’s Fed head independence dead? Trump outfoxes himself this time
By Jeffrey SonnenfeldJanuary 13, 2026
8 hours ago
paramount
CommentaryM&A
A cautionary Hollywood tale: the Ellisons’ lose-lose Paramount positioning
By Jeffrey Sonnenfeld and Stephen HenriquesJanuary 12, 2026
1 day ago
Walken
Commentarybeverages
Molson Coors CEO: We’re doing our part to solve society’s ‘occasion problem’ – and we’re getting some unexpected help
By Rahul GoyalJanuary 12, 2026
1 day ago
AsiaChina
What global executives need to ask about China in 2026
By Joe Ngai and Jeongmin SeongJanuary 11, 2026
2 days ago
Justin Harlan
Commentaryremote work
I run one of America’s most successful remote work programs and the critics are right. Their solutions are all wrong, though
By Justin HarlanJanuary 11, 2026
2 days ago
Gene Ludwig
Commentaryaffordability
Millions of Americans are grappling with years of declining economic wellbeing and affordability needs a rethink
By Gene Ludwig and Shannon MeyerJanuary 11, 2026
2 days ago

Most Popular

placeholder alt text
Economy
Treasury spent $276 billion in interest on the national debt in the final three months of 2025, says the CBO—up $30 billion from a year prior
By Eleanor PringleJanuary 12, 2026
1 day ago
placeholder alt text
Economy
‘Sell America’: Investors dump U.S. assets in fear of the end of Fed independence
By Jim EdwardsJanuary 12, 2026
1 day ago
placeholder alt text
Newsletters
The oil CEO who stood up to Trump is a follower of the disciplined 'Exxon way' and has a history of blunt statements
By Jordan BlumJanuary 13, 2026
10 hours ago
placeholder alt text
Success
An exec at $62 billion giant Colgate says Gen Z workers, despite getting flak for being woke and lazy, are actually ‘pushing us to get better’
By Emma BurleighJanuary 10, 2026
3 days ago
placeholder alt text
Tech
Elon Musk asked people to upload their medical data to X so his AI company could learn to interpret MRIs and CT scans
By Sasha RogelbergJanuary 11, 2026
2 days ago
placeholder alt text
Real Estate
'Something big' just happened in the U.S. housing market, real estate CEO says. And it could mean the difference of being able to buy a home or not
By Sydney LakeJanuary 12, 2026
1 day ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.